Merck & Co., Inc. (MRK) Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., as President of Merck Research Laboratories (MRK); Peter S. Kim, Ph.D., to Retire
3/7/2013 6:28:45 AM
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Roger M. Perlmutter, M.D., Ph.D., as executive vice president and president of Merck Research Laboratories (MRL), effective April 15. Dr. Perlmutter will succeed Peter S. Kim, Ph.D., who has served in the role since 2003. To ensure a seamless transition, Dr. Perlmutter and Dr. Kim will work closely together for an initial period, after which Dr. Kim will remain with the company as an advisor until his retirement in August.